APA (7th ed.) Citation

Mayer, E. L., Dhakil, S., Patel, T., Sundaram, S., Fabian, C., Kozloff, M., . . . Burstein, H. J. (2010). SABRE-B: An evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer. Annals of Oncology, 21(12), 2370. https://doi.org/10.1093/annonc/mdq260

Chicago Style (17th ed.) Citation

Mayer, E. L., et al. "SABRE-B: An Evaluation of Paclitaxel and Bevacizumab with or Without Sunitinib as First-line Treatment of Metastatic Breast Cancer." Annals of Oncology 21, no. 12 (2010): 2370. https://doi.org/10.1093/annonc/mdq260.

MLA (9th ed.) Citation

Mayer, E. L., et al. "SABRE-B: An Evaluation of Paclitaxel and Bevacizumab with or Without Sunitinib as First-line Treatment of Metastatic Breast Cancer." Annals of Oncology, vol. 21, no. 12, 2010, p. 2370, https://doi.org/10.1093/annonc/mdq260.